Press Releases July 2, 2026 04:05 PM

Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026

Merit Medical Systems schedules Q2 2026 earnings release and investor conference call for July 30, 2026

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
MMSI

Merit Medical Systems, a global healthcare technology company, announced that it will release its financial results for Q2 2026 after market close on July 30, 2026, and will host a conference call that same day to discuss the results. The company specializes in developing and distributing proprietary medical devices for interventional, diagnostic, and therapeutic procedures across multiple medical specialties.

Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026
MMSI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Earnings release scheduled for after market close on July 30, 2026.
  • Conference call and webcast planned the same day to discuss financial results.
  • Merit Medical Systems develops and distributes medical devices across cardiology, radiology, oncology, critical care, and endoscopy.

SOUTH JORDAN, Utah, July 02, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that it will release its financial results for the quarter ended June 30, 2026, after the close of the stock market on Thursday, July 30, 2026. Merit plans to hold its investor conference call on the same day (Thursday, July 30, 2026) at 4:30 p.m. Eastern (3:30 p.m. Central, 2:30 p.m. Mountain, and 1:30 p.m. Pacific).

To access the conference call, please pre-register using the following link. Registrants will receive confirmation with dial-in details.

A live webcast and slide deck can be accessed using this link. A link to both register for the conference call and view the webcast will be made available at www.merit.com.

ABOUT MERIT
Founded in 1987, Merit is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,500 people worldwide.

Contacts:

 PR/Media Inquiries:
Sarah Comstock
Merit MedicalInvestor Inquiries:
Mike Piccinino, CFA, IRC
ICR Healthcare+1-801-432-2864+1-443-213-0509sarah.comstock@[email protected]

Risks

  • Financial results may not meet market expectations, impacting stock performance.
  • General market volatility around earnings season can lead to price fluctuations.
  • Healthcare regulatory changes and market demand dynamics could affect future performance.

More from Press Releases

CN to Report Second-Quarter 2026 Financial and Operating Results on July 24, 2026 Jul 3, 2026 FSI ANNOUNCES THE COMPANY HAS TRADED EQUITY IN THE FLORIDA LLC FOR EXCLUSIVE PRODUCT RIGHTS Jul 3, 2026 Critical Metals Corp. Provides Update on Proposed Acquisition of European Lithium Jul 3, 2026 Alarum Technologies Provides Update Regarding Recent Law Enforcement Action Jul 3, 2026 Niu Technologies Provides Second Quarter 2026 Sales Volume Update Jul 3, 2026